OTCMKTS:AOXG Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis $0.0075 0.00 (0.00%) As of 07/7/2025 02:51 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Aoxing Pharmaceutical Stock (OTCMKTS:AOXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aoxing Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.0075▼$0.008050-Day Range$0.0066▼$0.011852-Week Range$0.0046▼$0.0178Volume80,360 shsAverage Volume5,649 shsMarket Capitalization$2.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China. Read More Receive AOXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address AOXG Stock News HeadlinesTeva Pharmaceutical Industries Limited (TEVA)April 20, 2024 | finance.yahoo.comAoxing Pharmaceutical Company, Inc. (AOXG)January 23, 2024 | finance.yahoo.comThis Cold War “Accident” Could Unleash New $100 Trillion AI BoomObscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.July 8 at 2:00 AM | Brownstone Research (Ad)Aoxing Pharmaceutical Co Inc AOXGDecember 16, 2023 | morningstar.comMOPHLY Ono Pharmaceutical Co., Ltd.November 23, 2023 | seekingalpha.comAoxing Pharmaceutical Co (OTC:AOXG), Analyst Ratings, Price Targets, PredictionsJuly 12, 2022 | benzinga.comSee More Headlines AOXG Stock Analysis - Frequently Asked Questions How have AOXG shares performed this year? Aoxing Pharmaceutical's stock was trading at $0.0071 at the start of the year. Since then, AOXG shares have increased by 5.6% and is now trading at $0.0075. How were Aoxing Pharmaceutical's earnings last quarter? Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) issued its earnings results on Monday, May, 16th. The company reported $0.01 EPS for the quarter. The business earned $6.56 million during the quarter. How do I buy shares of Aoxing Pharmaceutical? Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aoxing Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC) and Edap Tms (EDAP). Company Calendar Last Earnings5/16/2016Today7/07/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:AOXG Previous SymbolNYSEMKT:AXN CIKN/A Webaxzyen.icm.cn Phone(646) 367-1747Fax646-367-1747Employees350Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares381,210,000Free Float313,354,000Market Cap$2.86 million OptionableNot Optionable Beta6.73 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (OTCMKTS:AOXG) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aoxing Pharmaceutical Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aoxing Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.